Overview

Ardelyx, Inc. is a biopharmaceutical company dedicated to developing innovative therapies to enhance patient well-being by addressing unmet medical needs. The company's primary focus is on the treatment of kidney and cardiorenal diseases.

Therapeutic areas

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832023-07-24

    Failure to develop written procedures

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.